TENAX THERAPEUTICS, INC.·4

Jan 12, 5:02 PM ET

Jebsen Michael B 4

4 · TENAX THERAPEUTICS, INC. · Filed Jan 12, 2021

Insider Transaction Report

Form 4
Period: 2021-01-05
Jebsen Michael B
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2021-01-05+70,00070,000 total
    Exercise: $1.85From: 2022-01-05Exp: 2031-01-05Common stock (70,000 underlying)

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT